ZINFORO® (ceftaroline fosamil)
Prescribing information is available at the bottom of this page.
Consideration should be given to official guidance on the appropriate use of antibacterial agents. Organisms that are resistant to ZINFORO® can occur at variable rates between countries and between healthcare facilities within countries. If ZINFORO® is commenced before susceptibility test results are available, then local information on the risk of encountering resistant organisms should be taken into consideration.
Abbreviations: AMR, antimicrobial resistance; MoA, mode of action
Reference: 1. ZINFORO®. Summary of Product Characteristics.
Date of Preparation: June 2018